Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p2884 has 246 genes in the original annotation. Currently, there are 180 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
221061	FAM171A1	C10orf38	family with sequence similarity 171 member A1	10p13
10133	OPTN	ALS12 \| FIP2 \| GLC1E \| HIP7 \| HYPL \| NRP \| TFIIIA-INTP	optineurin	10p13
2625	GATA3	HDR \| HDRS	GATA binding protein 3	10p15
1791	DNTT	TDT	DNA nucleotidylexotransferase	10q23-q24
29760	BLNK	AGM4 \| BASH \| BLNK-S \| LY57 \| SLP-65 \| SLP65 \| bca	B-cell linker	10q23.2-q23.33
3983	ABLIM1	ABLIM \| LIMAB1 \| LIMATIN \| abLIM-1	actin binding LIM protein 1	10q25
1571	CYP2E1	CPE1 \| CYP2E \| P450-J \| P450C2E	cytochrome P450 family 2 subfamily E member 1	10q26.3
5140	PDE3B	HcGIP1 \| cGIPDE1	phosphodiesterase 3B	11p15.1
10418	SPON1	VSGP/F-spondin \| f-spondin	spondin 1	11p15.2
8642	DCHS1	CDH19 \| CDH25 \| CDHR6 \| FIB1 \| MVP2 \| PCDH16 \| VMLDS1	dachsous cadherin-related 1	11p15.4
8519	IFITM1	9-27 \| CD225 \| DSPA2a \| IFI17 \| LEU13	interferon induced transmembrane protein 1	11p15.5
6947	TCN1	HC \| TC-1 \| TC1 \| TCI	transcobalamin 1	11q11-q12
710	SERPING1	C1IN \| C1INH \| C1NH \| HAE1 \| HAE2	serpin peptidase inhibitor, clade G (C1 inhibitor), member 1	11q12.1
9379	NRXN2	-	neurexin 2	11q13
9828	ARHGEF17	P164RHOGEF \| TEM4 \| p164-RhoGEF	Rho guanine nucleotide exchange factor 17	11q13.4
23052	ENDOD1	-	endonuclease domain containing 1	11q21
915	CD3D	CD3-DELTA \| IMD19 \| T3D	CD3d molecule	11q23
4684	NCAM1	CD56 \| MSK39 \| NCAM	neural cell adhesion molecule 1	11q23.1
6653	SORL1	C11orf32 \| LR11 \| LRP9 \| SORLA \| SorLA-1 \| gp250	sortilin-related receptor, L(DLR class) A repeats containing	11q23.2-q24.2
23365	ARHGEF12	LARG \| PRO2792	Rho guanine nucleotide exchange factor 12	11q23.3
2012	EMP1	CL-20 \| EMP-1 \| TMP	epithelial membrane protein 1	12p12.3
969	CD69	AIM \| BL-AC/P26 \| CLEC2C \| EA1 \| GP32/28 \| MLR-3	CD69 molecule	12p13
894	CCND2	KIAK0002 \| MPPH3	cyclin D2	12p13
81539	SLC38A1	ATA1 \| NAT2 \| SAT1 \| SNAT1	solute carrier family 38 member 1	12q13.11
217	ALDH2	ALDH-E2 \| ALDHI \| ALDM	aldehyde dehydrogenase 2 family (mitochondrial)	12q24.2
5426	POLE	CRCS12 \| FILS \| POLE1	polymerase (DNA) epsilon, catalytic subunit	12q24.3
10161	LPAR6	ARWH1 \| HYPT8 \| LAH3 \| P2RY5 \| P2Y5	lysophosphatidic acid receptor 6	13q14
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
1602	DACH1	DACH	dachshund family transcription factor 1	13q22
5911	RAP2A	K-REV \| KREV \| RAP2 \| RbBP-30	RAP2A, member of RAS oncogene family	13q34
2581	GALC	-	galactosylceramidase	14q31
8788	DLK1	DLK \| DLK-1 \| Delta1 \| FA1 \| PREF1 \| Pref-1 \| ZOG \| pG2	delta-like 1 homolog (Drosophila)	14q32
55384	MEG3	FP504 \| GTL2 \| LINC00023 \| NCRNA00023 \| PRO0518 \| PRO2160 \| onco-lncRNA-83 \| prebp1	maternally expressed 3 (non-protein coding)	14q32
51466	EVL	RNB6	Enah/Vasp-like	14q32.2
4734	NEDD4	NEDD4-1 \| RPF1	neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase	15q
2628	GATM	AGAT \| AT \| CCDS3	glycine amidinotransferase	15q21.1
53346	TM6SF1	-	transmembrane 6 superfamily member 1	15q24-q26
4205	MEF2A	ADCAD1 \| RSRFC4 \| RSRFC9 \| mef2	myocyte enhancer factor 2A	15q26
7041	TGFB1I1	ARA55 \| HIC-5 \| HIC5 \| TSC-5	transforming growth factor beta 1 induced transcript 1	16p11.2
930	CD19	B4 \| CVID3	CD19 molecule	16p11.2
64131	XYLT1	DBQD2 \| PXYLT1 \| XT-I \| XT1 \| XTI \| XYLTI	xylosyltransferase I	16p12.3
4261	CIITA	C2TA \| CIITAIV \| MHC2TA \| NLRA	class II, major histocompatibility complex, transactivator	16p13
4629	MYH11	AAT4 \| FAA4 \| SMHC \| SMMHC	myosin, heavy chain 11, smooth muscle	16p13.11
64428	NARFL	HPRN \| IOP1 \| LET1L \| PRN	nuclear prelamin A recognition factor-like	16p13.3
10232	MSLN	MPF \| SMRP	mesothelin	16p13.3
5176	SERPINF1	EPC-1 \| OI12 \| OI6 \| PEDF \| PIG35	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1	17p13.3
3728	JUP	ARVD12 \| CTNNG \| DP3 \| DPIII \| PDGB \| PKGB	junction plakoglobin	17q21
284119	PTRF	CAVIN \| CAVIN1 \| CGL4 \| FKSG13 \| cavin-1	polymerase I and transcript release factor	17q21.2
2535	FZD2	Fz2 \| fz-2 \| fzE2 \| hFz2	frizzled class receptor 2	17q21.31
9256	BZRAP1	PBR-IP \| PRAX-1 \| PRAX1 \| RIM-BP1 \| RIMBP1	benzodiazepine receptor (peripheral) associated protein 1	17q22
4353	MPO	-	myeloperoxidase	17q23.1
439921	MXRA7	PS1TP1 \| TMAP1	matrix-remodelling associated 7	17q25.1
924	CD7	GP40 \| LEU-9 \| TP41 \| Tp40	CD7 molecule	17q25.2-q25.3
5797	PTPRM	PTPRL1 \| R-PTP-MU \| RPTPM \| RPTPU \| hR-PTPu	protein tyrosine phosphatase, receptor type M	18p11.2
9331	B4GALT6	B4Gal-T6 \| beta4Gal-T6	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6	18q11
5366	PMAIP1	APR \| NOXA	phorbol-12-myristate-13-acetate-induced protein 1	18q21.32
5657	PRTN3	ACPA \| AGP7 \| C-ANCA \| CANCA \| MBN \| MBT \| NP-4 \| NP4 \| P29 \| PR-3 \| PR3	proteinase 3	19p13.3
5064	PALM	-	paralemmin	19p13.3
2788	GNG7	-	G protein subunit gamma 7	19p13.3
6929	TCF3	E2A \| E47 \| ITF1 \| TCF-3 \| VDIR \| bHLHb21	transcription factor 3	19p13.3
4037	LRP3	-	LDL receptor related protein 3	19q13.11
25999	CLIP3	CLIPR-59 \| CLIPR59 \| RSNL1	CAP-Gly domain containing linker protein 3	19q13.12
4680	CEACAM6	CD66c \| CEAL \| NCA	carcinoembryonic antigen related cell adhesion molecule 6	19q13.2
5739	PTGIR	IP \| PRIPR	prostaglandin I2 (prostacyclin) receptor (IP)	19q13.3
6689	SPIB	SPI-B	Spi-B transcription factor	19q13.33
54795	TRPM4	PFHB1B \| TRPM4B	transient receptor potential cation channel subfamily M member 4	19q13.33
914	CD2	LFA-2 \| SRBC \| T11	CD2 molecule	1p13.1
29899	GPSM2	CMCS \| DFNB82 \| LGN \| PINS	G-protein signaling modulator 2	1p13.3
8543	LMO4	-	LIM domain only 4	1p22.3
5142	PDE4B	DPDE4 \| PDEIVB	phosphodiesterase 4B	1p31
10964	IFI44L	C1orf29 \| GS3686	interferon induced protein 44 like	1p31.1
10561	IFI44	MTAP44 \| TLDC5 \| p44	interferon induced protein 44	1p31.1
205	AK4	AK 4 \| AK3 \| AK3L1 \| AK3L2	adenylate kinase 4	1p31.3
4352	MPL	C-MPL \| CD110 \| MPLV \| THCYT2 \| TPOR	MPL proto-oncogene, thrombopoietin receptor	1p34
1441	CSF3R	CD114 \| GCSFR	colony stimulating factor 3 receptor	1p35-p34.3
864	RUNX3	AML2 \| CBFA3 \| PEBP2aC	runt related transcription factor 3	1p36
3339	HSPG2	HSPG \| PLC \| PRCAN \| SJA \| SJS \| SJS1	heparan sulfate proteoglycan 2	1p36.1-p34
10903	MTMR11	CRA	myotubularin related protein 11	1q21.2
962	CD48	BCM1 \| BLAST \| BLAST1 \| MEM-102 \| SLAMF2 \| hCD48 \| mCD48	CD48 molecule	1q21.3-q22
2205	FCER1A	FCE1A \| FcERI	Fc fragment of IgE receptor Ia	1q23
116496	FAM129A	C1orf24 \| GIG39 \| NIBAN	family with sequence similarity 129 member A	1q25
5996	RGS1	1R20 \| BL34 \| HEL-S-87 \| IER1 \| IR20	regulator of G-protein signaling 1	1q31
947	CD34	-	CD34 molecule	1q32
7188	TRAF5	MGC:39780 \| RNF84	TNF receptor associated factor 5	1q32
1116	CHI3L1	ASRT7 \| CGP-39 \| GP-39 \| GP39 \| HC-gp39 \| HCGP-3P \| YKL-40 \| YKL40 \| YYL-40 \| hCGP-39	chitinase 3 like 1	1q32.1
54976	C20orf27	-	chromosome 20 open reading frame 27	20p13
671	BPI	BPIFD1 \| rBPI	bactericidal/permeability-increasing protein	20q11.23
26051	PPP1R16B	ANKRD4 \| TIMAP	protein phosphatase 1 regulatory subunit 16B	20q11.23
4318	MMP9	CLG4B \| GELB \| MANDP2 \| MMP-9	matrix metallopeptidase 9	20q13.12
10079	ATP9A	ATPIIA	ATPase phospholipid transporting 9A (putative)	20q13.2
351	APP	AAA \| ABETA \| ABPP \| AD1 \| APPI \| CTFgamma \| CVAP \| PN-II \| PN2	amyloid beta precursor protein	21q21.3
4599	MX1	IFI-78K \| IFI78 \| MX \| MxA	MX dynamin like GTPase 1	21q22.3
2078	ERG	erg-3 \| p55	v-ets avian erythroblastosis virus E26 oncogene homolog	21q22.3
25966	C2CD2	C21orf25 \| C21orf258 \| TMEM24L	C2 calcium-dependent domain containing 2	21q22.3
29799	YPEL1	FKSG3	yippee like 1	22q11.2
5625	PRODH	HSPOX2 \| PIG6 \| POX \| PRODH1 \| PRODH2 \| TP53I6	proline dehydrogenase (oxidase) 1	22q11.21
9145	SYNGR1	-	synaptogyrin 1	22q13.1
23683	PRKD3	EPK2 \| PKC-NU \| PKD3 \| PRKCN \| nPKC-NU	protein kinase D3	2p21
6711	SPTBN1	ELF \| HEL102 \| SPTB2 \| betaSpII	spectrin beta, non-erythrocytic 1	2p21
109	ADCY3	AC-III \| AC3	adenylate cyclase 3	2p23.3
28951	TRIB2	C5FW \| GS3955 \| TRB2	tribbles pseudokinase 2	2p24.3
7837	PXDN	COPOA \| D2S448 \| D2S448E \| MG50 \| PRG2 \| PXN \| VPO	peroxidasin	2p25
7535	ZAP70	SRK \| STCD \| STD \| TZK \| ZAP-70	zeta chain of T cell receptor associated protein kinase 70kDa	2q12
3655	ITGA6	CD49f \| ITGA6B \| VLA-6	integrin subunit alpha 6	2q31.1
10267	RAMP1	-	receptor (G protein-coupled) activity modifying protein 1	2q36-q37.1
5270	SERPINE2	GDN \| GDNPF \| PI-7 \| PI7 \| PN-1 \| PN1 \| PNI	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2	2q36.1
81618	ITM2C	BRI3 \| BRICD2C \| E25 \| E25C \| ITM3	integral membrane protein 2C	2q37
23677	SH3BP4	BOG25 \| TTP	SH3-domain binding protein 4	2q37.1-q37.2
6091	ROBO1	DUTT1 \| SAX3	roundabout guidance receptor 1	3p12
2317	FLNB	ABP-278 \| ABP-280 \| AOI \| FH1 \| FLN-B \| FLN1L \| LRS1 \| SCT \| TABP \| TAP	filamin B	3p14.3
4485	MST1	D3F15S2 \| DNF15S2 \| HGFL \| MSP \| NF15S2	macrophage stimulating 1	3p21
9254	CACNA2D2	CACNA2D	calcium voltage-gated channel auxiliary subunit alpha2delta 2	3p21.3
25907	TMEM158	BBP \| RIS1 \| p40BBP	transmembrane protein 158 (gene/pseudogene)	3p21.3
729230	CCR2	CC-CKR-2 \| CCR-2 \| CCR2A \| CCR2B \| CD192 \| CKR2 \| CKR2A \| CKR2B \| CMKBR2 \| MCP-1-R	C-C motif chemokine receptor 2	3p21.31
7200	TRH	Pro-TRH \| TRF	thyrotropin releasing hormone	3q13.3-q21
23129	PLXND1	PLEXD1	plexin D1	3q22.1
2122	MECOM	AML1-EVI-1 \| EVI1 \| MDS1 \| MDS1-EVI1 \| PRDM3 \| RUSAT2	MDS1 and EVI1 complex locus	3q26.2
116984	ARAP2	CENTD1 \| PARX	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	4p14
952	CD38	ADPRC 1 \| ADPRC1	CD38 molecule	4p15
6286	S100P	MIG9	S100 calcium binding protein P	4p16
55351	STK32B	HSA250839 \| STK32 \| STKG6 \| YANK2	serine/threonine kinase 32B	4p16.2
3490	IGFBP7	AGM \| FSTL2 \| IBP-7 \| IGFBP-7 \| IGFBP-7v \| IGFBPRP1 \| MAC25 \| PSF \| RAMSVPS \| TAF	insulin like growth factor binding protein 7	4q12
3815	KIT	C-Kit \| CD117 \| PBT \| SCFR	KIT proto-oncogene receptor tyrosine kinase	4q12
26228	STAP1	BRDG1 \| STAP-1	signal transducing adaptor family member 1	4q13.2
6622	SNCA	NACP \| PARK1 \| PARK4 \| PD1	synuclein alpha	4q21
27306	HPGDS	GSTS \| GSTS1 \| GSTS1-1 \| PGD2 \| PGDS	hematopoietic prostaglandin D synthase	4q22.3
55024	BANK1	BANK	B-cell scaffold protein with ankyrin repeats 1	4q24
10252	SPRY1	hSPRY1	sprouty RTK signaling antagonist 1	4q28.1
5734	PTGER4	EP4 \| EP4R	prostaglandin E receptor 4	5p13.1
4883	NPR3	ANP-C \| ANPR-C \| ANPRC \| C5orf23 \| GUCY2B \| NPR-C \| NPRC	natriuretic peptide receptor 3	5p13.3
5066	PAM	PAL \| PHM	peptidylglycine alpha-amidating monooxygenase	5q14-q21
10184	LHFPL2	-	lipoma HMGIC fusion partner-like 2	5q14.1
256987	SERINC5	C5orf12 \| TPO1	serine incorporator 5	5q14.1
4208	MEF2C	C5DELq14.3 \| DEL5q14.3	myocyte enhancer factor 2C	5q14.3
22836	RHOBTB3	-	Rho related BTB domain containing 3	5q15
7045	TGFBI	BIGH3 \| CDB1 \| CDG2 \| CDGG1 \| CSD \| CSD1 \| CSD2 \| CSD3 \| EBMD \| LCD1	transforming growth factor beta induced	5q31
7422	VEGFA	MVCD1 \| VEGF \| VPF	vascular endothelial growth factor A	6p12
27242	TNFRSF21	BM-018 \| CD358 \| DR6	tumor necrosis factor receptor superfamily member 21	6p21.1
3113	HLA-DPA1	DP(W3) \| DP(W4) \| HLA-DP1A \| HLADP \| HLASB \| PLT1	major histocompatibility complex, class II, DP alpha 1	6p21.3
3115	HLA-DPB1	DPB1 \| HLA-DP \| HLA-DP1B \| HLA-DPB	major histocompatibility complex, class II, DP beta 1	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
8339	HIST1H2BG	H2B.1A \| H2B/a \| H2BFA \| dJ221C16.8	histone cluster 1, H2bg	6p22.2
2766	GMPR	GMPR 1 \| GMPR1	guanosine monophosphate reductase	6p23
4907	NT5E	CALJA \| CD73 \| E5NT \| NT \| NT5 \| NTE \| eN \| eNT	5'-nucleotidase ecto	6q14-q21
58528	RRAGD	RAGD \| bA11D8.2.1	Ras related GTP binding D	6q15
8936	WASF1	SCAR1 \| WAVE \| WAVE1	WAS protein family member 1	6q21
4121	MAN1A1	HUMM3 \| HUMM9 \| MAN9	mannosidase alpha class 1A member 1	6q22
29940	DSE	DSEP \| DSEPI \| EDSMC2 \| SART-2 \| SART2	dermatan sulfate epimerase	6q22
2697	GJA1	AVSD3 \| CMDR \| CX43 \| EKVP \| GJAL \| HLHS1 \| HSS \| ODDD \| PPKCA	gap junction protein alpha 1	6q22.31
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
9805	SCRN1	SES1	secernin 1	7p14.3
27075	TSPAN13	NET-6 \| NET6 \| TM4SF13	tetraspanin 13	7p21.1
3315	HSPB1	CMT2F \| HEL-S-102 \| HMN2B \| HS.76067 \| HSP27 \| HSP28 \| Hsp25 \| SRP27	heat shock protein family B (small) member 1	7q11.23
2770	GNAI1	Gi	G protein subunit alpha i1	7q21
3082	HGF	DFNB39 \| F-TCF \| HGFB \| HPTA \| SF	hepatocyte growth factor	7q21.1
5243	ABCB1	ABC20 \| CD243 \| CLCS \| GP170 \| MDR1 \| P-GP \| PGY1	ATP binding cassette subfamily B member 1	7q21.12
857	CAV1	BSCL3 \| CGL3 \| LCCNS \| MSTP085 \| PPH3 \| VIP21	caveolin 1	7q31.1
29969	MDFIC	HIC	MyoD family inhibitor domain containing	7q31.1-q31.2
4232	MEST	PEG1	mesoderm specific transcript	7q32
2260	FGFR1	BFGFR \| CD331 \| CEK \| FGFBR \| FGFR-1 \| FLG \| FLT-2 \| FLT2 \| HBGFR \| HH2 \| HRTFDS \| KAL2 \| N-SAM \| OGD \| bFGF-R-1	fibroblast growth factor receptor 1	8p11.23-p11.22
11030	RBPMS	HERMES	RNA binding protein with multiple splicing	8p12
55790	CSGALNACT1	CSGalNAcT-1 \| ChGn \| beta4GalNAcT	chondroitin sulfate N-acetylgalactosaminyltransferase 1	8p21.3
1808	DPYSL2	CRMP-2 \| CRMP2 \| DHPRP2 \| DRP-2 \| DRP2 \| N2A3 \| ULIP-2 \| ULIP2	dihydropyrimidinase like 2	8p22-p21
9705	ST18	NZF3 \| ZC2HC10 \| ZNF387	suppression of tumorigenicity 18, zinc finger	8q11.23
9760	TOX	TOX1	thymocyte selection associated high mobility group box	8q12.1
862	RUNX1T1	AML1-MTG8 \| AML1T1 \| CBFA2T1 \| CDR \| ETO \| MTG8 \| ZMYND2	runt related transcription factor 1; translocated to, 1 (cyclin D related)	8q22
79870	BAALC	-	brain and acute leukemia, cytoplasmic	8q22.3
8323	FZD6	FZ-6 \| FZ6 \| HFZ6 \| NDNC10	frizzled class receptor 6	8q22.3-q23.1
64798	DEPTOR	DEP.6 \| DEPDC6	DEP domain containing MTOR-interacting protein	8q24.12
22882	ZHX2	AFR1 \| RAF	zinc fingers and homeoboxes 2	8q24.13
4300	MLLT3	AF9 \| YEATS3	myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3	9p22
7436	VLDLR	CAMRQ1 \| CARMQ1 \| CHRMQ1 \| VLDLRCH	very low density lipoprotein receptor	9p24
7357	UGCG	GCS \| GLCT1	UDP-glucose ceramide glucosyltransferase	9q31
2934	GSN	ADF \| AGEL	gelsolin	9q33
3934	LCN2	24p3 \| MSFI \| NGAL \| p25	lipocalin 2	9q34
51162	EGFL7	NEU1 \| VE-STATIN \| ZNEU1	EGF like domain multiple 7	9q34.3
212	ALAS2	ALAS-E \| ALASE \| ANH1 \| ASB \| XLDPP \| XLEPP \| XLSA	5'-aminolevulinate synthase 2	Xp11.21
7102	TSPAN7	A15 \| CCG-B7 \| CD231 \| DXS1692E \| MRX58 \| MXS1 \| TALLA-1 \| TM4SF2 \| TM4SF2b	tetraspanin 7	Xp11.4
2824	GPM6B	M6B	glycoprotein M6B	Xp22.2
2258	FGF13	FGF-13 \| FGF2 \| FHF-2 \| FHF2	fibroblast growth factor 13	Xq26.3